Tengjun Biotechnology's total assets for Q2 2023 were $438.96M, an increase of 152.39% from the previous quarter. TJBH total liabilities were $423.70M for the fiscal quarter, a 167.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.